Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Cardiovascular risk management in patients using antipsychotics: it is time to take action
by
Jakobs, Kirsti M.
, Bischoff, Erik W. M. A.
, Assendelft, Willem J. J.
in
Analysis
/ Antipsychotic agents
/ Antipsychotic Agents - adverse effects
/ Antipsychotic drugs
/ Antipsychotics
/ Biomedicine
/ Cardiovascular diseases
/ Cardiovascular Diseases - epidemiology
/ Cardiovascular risk management
/ Cholesterol
/ Collaboration
/ Commentary
/ Complications and side effects
/ Disease sex factors
/ Drugs
/ Female
/ Health risks
/ Heart Disease Risk Factors
/ Humans
/ Male
/ Medicine
/ Medicine & Public Health
/ Mental disorders
/ Myocardial Ischemia
/ Patients
/ Physicians
/ Prescription drugs
/ Prevention
/ Primary care
/ Primary Health Care
/ Psychotropic drugs
/ Retrospective Studies
/ Risk Factors
/ Risk management
/ Sex factors in disease
/ Side effects
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cardiovascular risk management in patients using antipsychotics: it is time to take action
by
Jakobs, Kirsti M.
, Bischoff, Erik W. M. A.
, Assendelft, Willem J. J.
in
Analysis
/ Antipsychotic agents
/ Antipsychotic Agents - adverse effects
/ Antipsychotic drugs
/ Antipsychotics
/ Biomedicine
/ Cardiovascular diseases
/ Cardiovascular Diseases - epidemiology
/ Cardiovascular risk management
/ Cholesterol
/ Collaboration
/ Commentary
/ Complications and side effects
/ Disease sex factors
/ Drugs
/ Female
/ Health risks
/ Heart Disease Risk Factors
/ Humans
/ Male
/ Medicine
/ Medicine & Public Health
/ Mental disorders
/ Myocardial Ischemia
/ Patients
/ Physicians
/ Prescription drugs
/ Prevention
/ Primary care
/ Primary Health Care
/ Psychotropic drugs
/ Retrospective Studies
/ Risk Factors
/ Risk management
/ Sex factors in disease
/ Side effects
2020
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Cardiovascular risk management in patients using antipsychotics: it is time to take action
by
Jakobs, Kirsti M.
, Bischoff, Erik W. M. A.
, Assendelft, Willem J. J.
in
Analysis
/ Antipsychotic agents
/ Antipsychotic Agents - adverse effects
/ Antipsychotic drugs
/ Antipsychotics
/ Biomedicine
/ Cardiovascular diseases
/ Cardiovascular Diseases - epidemiology
/ Cardiovascular risk management
/ Cholesterol
/ Collaboration
/ Commentary
/ Complications and side effects
/ Disease sex factors
/ Drugs
/ Female
/ Health risks
/ Heart Disease Risk Factors
/ Humans
/ Male
/ Medicine
/ Medicine & Public Health
/ Mental disorders
/ Myocardial Ischemia
/ Patients
/ Physicians
/ Prescription drugs
/ Prevention
/ Primary care
/ Primary Health Care
/ Psychotropic drugs
/ Retrospective Studies
/ Risk Factors
/ Risk management
/ Sex factors in disease
/ Side effects
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Cardiovascular risk management in patients using antipsychotics: it is time to take action
Journal Article
Cardiovascular risk management in patients using antipsychotics: it is time to take action
2020
Request Book From Autostore
and Choose the Collection Method
Overview
[...]of such increased use, long-term side effects of antipsychotic drugs may increase the burden on patients and healthcare services globally. Important known intermediate variables, like cholesterol and blood glucose level, and an unhealthy lifestyle, were not taken into account. [...]confounding by indication cannot be ruled out. [...]dose reduction and switching to an antipsychotic drug with a better metabolic profile are promising strategies to lower cardiometabolic risk. [...]barriers in access and communication between family physicians and patients using antipsychotic drugs may further complicate implementation of cardiovascular risk screening and treatment. Time to take action Given the complex nature of causal factors (indications for prescription), the unknown impact of the various intermediate factors (pathophysiological and biochemical parameters; lifestyle factors), and the unknown effectiveness of the required complex interventions, we argue that the study by Lai and colleagues is exploratory in nature and should be applied carefully in clinical practice.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
This website uses cookies to ensure you get the best experience on our website.